Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort ascending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort ascending Date Posted
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Laboratorijski analitik (m/ž/d) / QC Analyst (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 22, 2024
Quality Assurance Associate (Europe) Warsaw Poland Operations Innovative Medicines Quality Oct 21, 2024
QA Operations Specialist Tuas Bay Lane Singapore Operations Innovative Medicines Quality Oct 21, 2024
Associate, Country QA Compliance Head Office (Japan) (Pharmaceuticals) Japan Operations Innovative Medicines Quality Oct 22, 2024
Sr. eCompliance Specialist Hyderabad (Office) India Operations Innovative Medicines Quality Oct 22, 2024
Specialist kontrole kakovosti II / Specialist laboratorijske opreme (m/ž/d) , Ljubjana Ljubljana Slovenia Operations Innovative Medicines Quality Oct 18, 2024
Quality Business Excellence Coordinator INSURGENTES Mexico Operations Innovative Medicines Quality Oct 18, 2024
Specialist za analitiko v Centru za testiranje surovin (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 20, 2024
Laboratorijski analitik v medfazni analitiki (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 20, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 21, 2024
Sr. eCompliance Specialist Hyderabad (Office) India Operations Innovative Medicines Quality Oct 21, 2024
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Oct 16, 2024
QC Team Leader - Microbiology Tuas Bay Lane Singapore Operations Innovative Medicines Quality Oct 10, 2024
NCQ QA Manager Taipei Taiwan Operations Innovative Medicines Quality Oct 20, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Investigation Expert Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Oct 17, 2024
Lead, QSRC (Quality System Regulatory Compliance) Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 17, 2024
Ekspert upravljanja kakovosti za proces proizvodnje bioloških učinkovin (m/ž/d) / QA expert for the production process of biological agents (m/f/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Laboratorijski analitik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Specialist kontrole kakovosti (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
AS&T specialist (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Digital Quality Control specialist INSURGENTES Mexico Operations Innovative Medicines Quality Oct 17, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Good Clinical Practices and Pharmacovigilance Sr. Auditor INSURGENTES Mexico Operations Innovative Medicines Quality Oct 11, 2024
Global QMS RDQ Senior Specialist Hyderabad (Office) India Development Innovative Medicines Quality Oct 13, 2024
Načrtovalec izvedbe laboratorijskih analiz (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 14, 2024
GCP/PV Auditor Barcelona Provincial Spain Operations Innovative Medicines Quality Oct 14, 2024
QA Operations Expert Kundl Austria Operations Innovative Medicines Quality Oct 14, 2024
Ekspert upravljanja kakovosti zunanjih dobaviteljev (m/ž/d) / Quality Assurance Manager for external suppliers (m/f/d) (ESO FDF II) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 15, 2024
Labormitarbeiter - visuelle Inspektion (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Labortechniker / QC Analyst I (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
QA Operations Manager Warsaw Poland Operations Innovative Medicines Quality Oct 24, 2024
Specialist QA Operations Selangor Malaysia Operations Innovative Medicines Quality Oct 24, 2024
Specialist upravljanja kakovosti za področje upravljanja kakovosti prostorov, opreme, HVAC sistemov in medijev (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 24, 2024
Specialist upravljanja kakovosti za podporo laboratorijem (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 24, 2024
Quality Compliance Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Oct 24, 2024
QC Specialist I Tuas Bay Lane Singapore Operations Innovative Medicines Quality Oct 25, 2024
QC Specialist II (m/w/d), Schaftenau&Kundl, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 25, 2024
QA Operations Team Leader Kundl Austria Operations Innovative Medicines Quality Oct 25, 2024
AD, QA, Evaluations and Integrations Cambridge (USA) USA Biomedical Research Pharma Research Quality Oct 25, 2024
QA Specialist APQR INSURGENTES Mexico Operations Innovative Medicines Quality Sep 03, 2024
Quality Operations Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Oct 10, 2024
QC Analyst III Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 10, 2024
Analyst – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 10, 2024
QC Analyst Ivrea Italy International Innovative Medicines Quality Oct 11, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only